title: Endovascular repair of the thoracic aorta: lessons learned.
abstract: BACKGROUND
  Available information on outcome and best strategies for thoracic endovascular repair is somewhat limited and unclear. We sought to gain a better understanding of these issues through a retrospective review of our 8-year clinical experience in the treatment of thoracic aortic aneurysms and dissections.
  
  
  METHODS
  A retrospective chart review of 186 patients undergoing stent-graft repair of thoracic aortic lesions at our institution during the 92-month period ending on December 31, 2004 was performed. Patients were divided into two groups based on the indication for treatment; group A had thoracic aortic aneurysms (TAA) and group B had type B aortic dissections (TBAD). Both groups were analyzed for outcome variables including technical success, mortality, major morbidity, endoleak rate and type, secondary endovascular interventions, and long-term survival. Mean follow-up was 40 months (range, 1 to 92 months).
  
  
  RESULTS
  Compared to group B, group A patients were older and had a higher incidence of peripheral vascular disease and chronic obstructive pulmonary disease. Sixty percent of all patients were American Society of Anesthesiologists class III and the remainder were class IV (38.3%) and V (1.7%). The procedure was completed in 180 patients (96.7%), with all 6 failures being access-related. The average procedure time was 149 minutes (range, 72 to 405). The 30-day mortality was 4.7% (9 patients), and serious morbidity was 19.9% (37 patients). Eight patients (4.3%) developed spinal cord ischemia, 4 immediately after the procedure and 4 delayed (1 to 3 days). Total hospital length of stay averaged 6.7 days. Secondary endovascular interventions were successful in 17 patients with angiographically confirmed endoleaks (type I and III). At an average follow-up of 40 months, freedom from all-cause mortality was 62.5% in group A and 58.1% in group B.
  
  
  CONCLUSIONS
  Stent-graft repair for TAA and TBAD can be achieved with high technical success and comparatively low rates of morbidity and mortality. Midterm survival appears to be favorable. Further refinements in device technology and procedural techniques are needed.
authors.affiliation: Center for Vascular Intervention, Division of Vascular Surgery, Union Memorial Hospital, MedStar Health, Baltimore, Maryland, USA. frank.criado@medstar.net
authors.forename: Frank J
authors.initials: FJ
authors.lastname: Criado
authors.forename: Omran R
authors.initials: OR
authors.lastname: Abul-Khoudoud
authors.forename: Gregory S
authors.initials: GS
authors.lastname: Domer
authors.forename: Christine
authors.initials: C
authors.lastname: McKendrick
authors.forename: Mark
authors.initials: M
authors.lastname: Zuzga
authors.forename: Nancy S
authors.initials: NS
authors.lastname: Clark
authors.forename: Kerry
authors.initials: K
authors.lastname: Monaghan
authors.forename: Marcos F
authors.initials: MF
authors.lastname: Barnatan
mesh_terms: D000368:Aged; D000784:Aortic Dissection / Q000601:surgery*; D017545:Aortic Aneurysm, Thoracic / Q000601:surgery*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000209:etiology; D012189:Retrospective Studies; D015607:Stents; D016019:Survival Analysis; D019737:Transplants; D016896:Treatment Outcome